Dr. Jose Net (IMAGE)
Caption
“As the first major randomized trial of AI in breast cancer screening in the U.S., this study represents a pivotal step,” said Jose Net, M.D., director of breast imaging services at Sylvester and co-principal investigator of the study. “Our goal is to rigorously and objectively assess AI’s impact — identifying who benefits and who may not. Radiologists remain firmly in control of all diagnostic decisions.”
Credit
Photo by Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content